Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
30–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Female with non child-bearing potential
Diagnosed Diabetes Mellitus patients treated with insulin alone or insulin in combination with other anti-diabetic drugs. Stable blood sugar control indicated by no changed treatment within 3 months prior to study start.
HbA1c below or equal to 11 % at screening (HbA1c value according to international DCCT standard)
You may not be if
Clinically significant illness or clinically relevant trauma, as judged by the investigator, within two weeks before the first administration of the IP
History of ischemic heart disease, stroke, transitorisk ischemic attack or symptomatic peripheral vascular disease
Clinically significant abnormalities in clinical chemistry, hematology, or urinalysis results.
